Growth Metrics

CorMedix (CRMD) Receivables - Net (2016 - 2025)

CorMedix has reported Receivables - Net over the past 12 years, most recently at $171.2 million for Q4 2025.

  • Quarterly results put Receivables - Net at $171.2 million for Q4 2025, up 231.5% from a year ago — trailing twelve months through Dec 2025 was $171.2 million (up 231.5% YoY), and the annual figure for FY2025 was $171.2 million, up 231.5%.
  • Receivables - Net reached $171.2 million in Q4 2025 per CRMD's latest filing, up from $158.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $171.2 million in Q4 2025 and bottomed at $2975.0 in Q1 2022.
  • Median Receivables - Net over the past 4 years was $957206.0 (2025), compared with a mean of $40.3 million.
  • The largest annual shift saw Receivables - Net tumbled 93.18% in 2022 before it surged 20696.87% in 2025.
  • Over 4 years, Receivables - Net stood at $45368.0 in 2021, then plummeted by 93.44% to $2975.0 in 2022, then skyrocketed by 1736168.91% to $51.7 million in 2024, then surged by 231.5% to $171.2 million in 2025.
  • Business Quant data shows Receivables - Net for CRMD at $171.2 million in Q4 2025, $158.6 million in Q3 2025, and $42.9 million in Q2 2025.